Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Kutna Hora

5 clinical trials in Kutna Hora, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Kutna Hora at a glance
5
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Kutna Hora

Open in trial search

A study testing how well AZD4144 works and how safe it is for adults with acute kidney injury caused by sepsis

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB

Anxiety

Not yet recruiting

Efficacy of Etifoxine in Adults with Adjustment Disorder with Anxiety: A Randomized, Double‑Blind, Placebo‑Controlled Trial

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Etifoxine Hydrochloride
  • Sponsor:Biocodex

Psoriasis

Not recruiting

Study on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Envudeucitinib
  • Sponsor:Alumis Inc.

Psoriasis

Not recruiting

Study on the Effectiveness and Safety of ESK-001 and Apremilast for Adults with Moderate to Severe Plaque Psoriasis

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Alumis Inc.

Dermatitis atopic

Not recruiting

Long-Term Safety Study of Dupilumab for Children and Teens with Atopic Dermatitis

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:0–17 years
  • Substances:Dupilumab
  • Sponsor:Regeneron Pharmaceuticals Inc.

Other cities in Czechia

The busiest research cities in the country

All 159 cities in Czechia

Clinical research in Kutna Hora

What the registry says about research in the country

01 Dermatology Research

Ongoing clinical trials focusing on plaque psoriasis treatments, evaluating novel therapeutic approaches for patients with moderate to severe symptoms. Research aims to determine long-term safety and effectiveness of innovative medications.

  • Moderate to Severe Plaque Psoriasis
  • Long-term Treatment Evaluation
  • Therapeutic Efficacy Assessment

Multiple studies are comparing new treatments against existing standards of care.

02 Pediatric Dermatology

Specialized research investigating treatments for young patients with atopic dermatitis, particularly focusing on long-term safety in children from 6 months to 18 years of age.

  • Pediatric Atopic Dermatitis
  • Long-term Safety Studies
  • Drug Delivery Innovation

Studies include evaluation of new delivery methods specifically designed for pediatric patients.

03 Therapeutic Innovation

Advanced clinical research examining novel treatment approaches for chronic skin conditions, with emphasis on both safety profiles and treatment effectiveness.

  • Innovative Drug Development
  • Safety Monitoring
  • Treatment Response Duration

Research includes comprehensive evaluation of new therapeutic options across different patient populations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.